sb 203580 has been researched along with Epithelial Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Fu, Y; Han, X; Postovit, LM; Steed, H; Zhou, J | 1 |
| Guo, H; Ji, M; Peng, Z; Shi, H; Shi, M; Xie, Y | 1 |
| Cong, Q; Jiang, W; Li, MJ; Wang, YS; Xu, CJ; Ye, B | 1 |
3 other study(ies) available for sb 203580 and Epithelial Neoplasms
| Article | Year |
|---|---|
Pharmacological Inhibition of p38 MAPK by SB203580 Increases Resistance to Carboplatin in A2780cp Cells and Promotes Growth in Primary Ovarian Cancer Cells.
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Humans; Imidazoles; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Tumor Cells, Cultured | 2018 |
Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin‑resistant ovarian cancer.
Topics: Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Imidazoles; Metformin; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Pyridines | 2014 |
[Effects and mechanisms of platelet-activating factor on the invasiveness of ovarian cancer cells in vitro].
Topics: Blood Platelets; Blotting, Western; Carcinoma, Ovarian Epithelial; Cell Migration Assays; Cyclic AMP Response Element-Binding Protein; Female; Humans; Imidazoles; In Vitro Techniques; Matrix Metalloproteinase 2; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridines; Receptors, G-Protein-Coupled; Time Factors | 2011 |